164 related articles for article (PubMed ID: 7392529)
1. [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
Bulla M; Delling G; Benz-Bohm G; Stock GJ; Sánchez de Reutter A; Ziegler R; Lühmann H; Severin M; Kalbitzer E; Manegold C
Klin Wochenschr; 1980 May; 58(10):511-9. PubMed ID: 7392529
[TBL] [Abstract][Full Text] [Related]
2. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G
Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957
[TBL] [Abstract][Full Text] [Related]
3. Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
Velentzas C; Oreopoulos DG; Pierratos A; Meema HE; Rabinovich S; Meindok H; Husdan H; Murray TM; Ogilvie R; Katirtzoglou A
Can Med Assoc J; 1981 Mar; 124(5):577-83. PubMed ID: 6894103
[TBL] [Abstract][Full Text] [Related]
4. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
Teitelbaum SL
Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
[No Abstract] [Full Text] [Related]
5. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Massry SG; Goldstein DA; Malluche HH
Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
[No Abstract] [Full Text] [Related]
6. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
Moorthy AV; Harrington AR; Mazess RB; Simpson DP
Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
Brickman AS; Sherrard DJ; Jowsey J; Singer FR; Baylink DJ; Maloney N; Massry SG; Norman AW; Coburn JW
Arch Intern Med; 1974 Nov; 134(5):883-8. PubMed ID: 4613310
[No Abstract] [Full Text] [Related]
10. 1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.
Váry L
Int Urol Nephrol; 1980; 12(3):241-7. PubMed ID: 7251289
[TBL] [Abstract][Full Text] [Related]
11. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
Pierides AM; Skillen AW; Ellis HA
J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
[TBL] [Abstract][Full Text] [Related]
12. Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
Baker LR; Muir JW; Cattell WR; Tucker KA; Sharman VL; Goodwin FJ; Marsh FP; Hately W; Morgan AG; de Saintonge DM
Contrib Nephrol; 1980; 18():147-51. PubMed ID: 7353373
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
Reutter FW; Sieber R; Olah AJ; Dambacher MA
Schweiz Med Wochenschr; 1979 Dec; 109(47):1880-3. PubMed ID: 531567
[TBL] [Abstract][Full Text] [Related]
14. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
Coburn JW; Brickman AS
Adv Exp Med Biol; 1978; 103():473-86. PubMed ID: 362852
[No Abstract] [Full Text] [Related]
15. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
[TBL] [Abstract][Full Text] [Related]
16. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
Chesney RW; Hamstra A; Jax DK; Mazess RB; DeLuca HF
Contrib Nephrol; 1980; 18():55-71. PubMed ID: 7353380
[No Abstract] [Full Text] [Related]
17. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
Chantraine JM; Davin JC; Lambrechts L; Heynen G
Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
[TBL] [Abstract][Full Text] [Related]
18. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
[No Abstract] [Full Text] [Related]
19. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol in dialysis patients.
Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC
Clin Pharmacol Ther; 1978 May; 23(5):515-9. PubMed ID: 205382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
